Referencia | Nombre | Unidad | Proveedor | Aplicacion | Clonalidad | Huésped | Reactividad | Precio | Hoja Técnica |
---|---|---|---|---|---|---|---|---|---|
Ab02490-10.3-BT | Anti-VEGFR2 [V1] | 1 mg | Absolute Antibody | ELISA; FC; functional assay | Human | Solicitar Precio | Solicitar | ||
Ab03790-10.0-BT | Anti-HCV E1 [5D2] | 1 mg | Absolute Antibody | ELISA; Neutralizing; SPR | Hepatitis C virus | Solicitar Precio | Solicitar | ||
Ab03824-23.0-BT | Anti-4Ig-B7H3 [8H9] | 1 mg | Absolute Antibody | WB; therapeutic; in vivo; IHC; IP | Human | Solicitar Precio | Solicitar | ||
Ab03821-23.0-BT | Anti-Transthyretin [TTR-1] | 1 mg | Absolute Antibody | WB; IHC; ELISA | Human | Solicitar Precio | Solicitar | ||
Ab03811-23.0 | Anti-MerTK [Ab2000] | 100 ug | Absolute Antibody | ELISA; Inhibition | Human | Solicitar Precio | Solicitar | ||
Ab03785-10.0 | Anti-PD-L1 [CA782] | 100 ug | Absolute Antibody | ELISA; SPR | Mouse | Solicitar Precio | Solicitar | ||
Ab00715-10.3 | Anti-VEGF [Bevacizumab] | 200 ug | Absolute Antibody | ELISA; IP; WB; Block; FC | Human | Solicitar Precio | Solicitar | ||
Ab03802-10.0-BT | Anti-VSTM5 [F03] | 1 mg | Absolute Antibody | FACS; ELISA | Human | Solicitar Precio | Solicitar | ||
Ab03830-10.0-BT | Anti-MUC1-C/ECD [6A6] | 1 mg | Absolute Antibody | FC; ELISA; WB | Human | Solicitar Precio | Solicitar | ||
Ab03790-10.0 | Anti-HCV E1 [5D2] | 100 ug | Absolute Antibody | ELISA; Neutralizing; SPR | Hepatitis C virus | Solicitar Precio | Solicitar | ||
Ab03804-10.0-BT | Anti-PD-1 [Anti-human PD-1 antibody] | 1 mg | Absolute Antibody | ELISA; Blocking; Inhibition | Human | Solicitar Precio | Solicitar | ||
Ab03798-10.0 | Anti-PVRIG [334MXX] | 100 ug | Absolute Antibody | FACS | Human | Solicitar Precio | Solicitar | ||
Ab00510-1.6-BT | Anti-Vaginolysin [23A2] | 1 mg | Absolute Antibody | ELISA; WB; Block | Other | Solicitar Precio | Solicitar | ||
Ab00511-10.7 | Anti-Vaginolysin [9B4] | 200 ug | Absolute Antibody | ELISA; WB; Block | Other | Solicitar Precio | Solicitar | ||
Ab03833-10.0 | Anti-CD98 [8-34B] | 100 ug | Absolute Antibody | Inhibition; in vivo; IHC; FACS; SPR | Human | Solicitar Precio | Solicitar | ||
Ab00715-10.3-BT | Anti-VEGF [Bevacizumab] | 1 mg | Absolute Antibody | ELISA; IP; WB; Block; FC | Human | Solicitar Precio | Solicitar | ||
Ab02839-10.3-BT | Anti-VEGF-D [VD1 (4A5)] | 1 mg | Absolute Antibody | Block; ELISA; IP; WB; IHC | Human | Solicitar Precio | Solicitar | ||
Ab03799-1.1 | Anti-FZD7 [Fab-1219] | 100 ug | Absolute Antibody | WB | Human | Solicitar Precio | Solicitar | ||
Ab02490-10.3 | Anti-VEGFR2 [V1] | 200 ug | Absolute Antibody | ELISA; FC; functional assay | Human | Solicitar Precio | Solicitar | ||
Ab03794-10.0-BT | Anti-CD44v6 [BIWA8] | 1 mg | Absolute Antibody | in vivo | Human | Solicitar Precio | Solicitar | ||
Ab03816-10.0 | Anti-Gn [Mab-2 (23B5-1)] | 100 ug | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Solicitar Precio | Solicitar | ||
Ab03810-30.11-BT | Anti-VEGF-D [3A] | 500 ug | Absolute Antibody | SPR | Human | Solicitar Precio | Solicitar | ||
Ab00339-10.7-BT | Anti-VEGF [A.4.6.1] | 1 mg | Absolute Antibody | ELISA; IP; WB; Block; FC; IHC | Human; Rat | Solicitar Precio | Solicitar | ||
Ab00715-10.29 | Anti-VEGF [Bevacizumab] | 100 ug | Absolute Antibody | ELISA; IP; WB; Block; FC | Human | Solicitar Precio | Solicitar | ||
Ab03784-10.0-BT | Anti-PD-L1 [BT613] | 1 mg | Absolute Antibody | SPR; blocking; in vitro; inhibition; in vivo | Human; Mouse | Solicitar Precio | Solicitar | ||
Ab03805-23.0 | Anti-PD-1 [6#] | 100 ug | Absolute Antibody | ELISA; blocking; SPR; inhibition | Human | Solicitar Precio | Solicitar | ||
Ab03807-1.1 | Anti-CTLA-4 [4.13.1] | 100 ug | Absolute Antibody | Human | Solicitar Precio | Solicitar | |||
Ab03799-10.0-BT | Anti-FZD7 [Fab-1219] | 1 mg | Absolute Antibody | WB | Human | Solicitar Precio | Solicitar | ||
Ab03805-23.0-BT | Anti-PD-1 [6#] | 1 mg | Absolute Antibody | ELISA; blocking; SPR; inhibition | Human | Solicitar Precio | Solicitar | ||
Ab03785-23.0 | Anti-PD-L1 [CA782] | 100 ug | Absolute Antibody | ELISA; SPR | Mouse | Solicitar Precio | Solicitar | ||
Ab03800-10.0 | Anti-FZD7 [Fab-1791] | 100 ug | Absolute Antibody | WB; in vitro; FC; IHC; blocking | Human | Solicitar Precio | Solicitar | ||
Ab03793-1.1 | Anti-CD44v6 [BIWA4] | 100 ug | Absolute Antibody | in vivo; ELISA; therapeutic; SPR | Human | Solicitar Precio | Solicitar | ||
Ab03844-1.1-BT | Anti-gp120 protein (CD4-binding domain) [448-D] | 1 mg | Absolute Antibody | ELISA; Neutralization; blocking | HIV-1 | Solicitar Precio | Solicitar | ||
Ab03800-1.1-BT | Anti-FZD7 [Fab-1791] | 1 mg | Absolute Antibody | WB; in vitro; FC; IHC; blocking | Human | Solicitar Precio | Solicitar | ||
Ab00136-10.7-BT | Anti-V5 epitope tag [SV5-P-K] | 500 ug | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Solicitar Precio | Solicitar | ||
Ab01919-1.29-BS | Anti-VAX2 [RAB-S34] | 1 mg | Absolute Antibody | FC; spiked-IP; IF | Human | Solicitar Precio | Solicitar | ||
Ab00511-10.6-BT | Anti-Vaginolysin [9B4] | 1 mg | Absolute Antibody | ELISA; WB; Block | Other | Solicitar Precio | Solicitar | ||
Ab03841-23.0 | Anti-Envelope protein E [6B6C-1] | 100 ug | Absolute Antibody | ELISA; WB | St. louis encephalitis virus (SLEV); Dengue virus | Solicitar Precio | Solicitar | ||
Ab03802-23.0 | Anti-VSTM5 [F03] | 100 ug | Absolute Antibody | FACS; ELISA | Human | Solicitar Precio | Solicitar | ||
Ab03844-23.0 | Anti-gp120 protein (CD4-binding domain) [448-D] | 100 ug | Absolute Antibody | ELISA; Neutralization; blocking | HIV-1 | Solicitar Precio | Solicitar | ||
Ab03791-23.0-BT | Anti-C3a Receptor [D1858G07] | 1 mg | Absolute Antibody | Human | Solicitar Precio | Solicitar | |||
Ab03836-21.0 | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] | 50 ug | Absolute Antibody | Cristallography; Neutralizing; SPR; WB | Severe Fever and Thrombocytopenic Syndrome Virus | Solicitar Precio | Solicitar | ||
Ab03797-23.0-BT | Anti-HLA/EBNA1 [anti-HLA-A0201/EBNA1 antibody] | 1 mg | Absolute Antibody | SPR; IHC; FC | Epstein-Barr virus | Solicitar Precio | Solicitar | ||
Ab03816-10.0-BT | Anti-Gn [Mab-2 (23B5-1)] | 1 mg | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Solicitar Precio | Solicitar | ||
Ab00766-3.3-BT | Anti-Vaccinia A33 glycoprotein [A2C7] | 1 mg | Absolute Antibody | IF; neutralization | Vaccinia virus | Solicitar Precio | Solicitar | ||
Ab03803-10.0-BT | Anti-ICOS ligand [Clone 325] | 1 mg | Absolute Antibody | inhibit, Block, ELISA, FC | Human | Solicitar Precio | Solicitar | ||
Ab03793-1.1-BT | Anti-CD44v6 [BIWA4] | 1 mg | Absolute Antibody | in vivo; ELISA; therapeutic; SPR | Human | Solicitar Precio | Solicitar | ||
Ab00510-1.6 | Anti-Vaginolysin [23A2] | 200 ug | Absolute Antibody | ELISA; WB; Block | Other | Solicitar Precio | Solicitar | ||
Ab03826-1.1-BT | Anti-EGFR [EGFR-8] | 1 mg | Absolute Antibody | ELISA; WB; Inhibition | Human | Solicitar Precio | Solicitar | ||
Ab03792-23.0-BT | Anti-C3a Receptor [D098G01] | 1 mg | Absolute Antibody | Human | Solicitar Precio | Solicitar |